Alkermes (ALKS) Competitor Comparison
We are evaluating the key criteria listed to compare Alkermes (ALKS) against its competitors in the Biotechnology industry.
Market Capitalization
35 / 368Gross Profits
13 / 278Total Revenue
14 / 300EBITDA
10 / 337Free Cashflow
8 / 352Quick Ratio
274 / 357Earnings per Share
12 / 359Dividend yield
0 / 6Total Cash
27 / 358Performance 3 years
99 / 368Performance 5 years
103 / 368Performance 10 years
143 / 368Linearity 3 years
27 / 368Linearity 5 years
91 / 368Linearity 10 years
78 / 368Total Rank
87 / 368Dividend Rank
341 / 368Valuation Rank
165 / 368Piotroski Rank
253 / 368Muliplier Rank
120 / 368Dividend yield - ALKS ranking 0 / 6
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.